Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera | Frequently asked questions about COVID-19 vaccination |
---|---|
mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-Cov-2 variants | Use of Pfizer-BioNTech COVID-19 vaccine: Clinical considerations |
Centers for Disease Control and Prevention | Centers for Disease Control and Prevention |
---|---|
FDA for emergency use authorization | Centers for Disease Control and Prevention |